An Economic Evaluation of the 2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Mild-to-Moderate Hypertension in Greece

In mild-to-moderate uncomplicated hypertension chlorthalidone is the most cost-effective agent. If it was the drug of choice to initiate treatment of uncomplicated hypertension, it would probably save the public insurance system organizations a great amount of expenses for benefit of the insured patients.